Welcome to DukeHealth.org.
Skip over navigation
  • Home
  • Patient and Visitor Info
  • Physicians
  • Services
  • Clinical Trials
  • Event Calendar
  • Locations
  • Health Library
  • About Duke Medicine

Quick Links

  • Appointments
  • Quality and Safety
Home > Clinical Trials > Neurobiology of Response Inhibition in Comorbid ADHD and Nicotine Dependence
Jumbo Large Regular Text:
Print
Clinical Trials

Neurobiology of Response Inhibition in Comorbid ADHD and Nicotine Dependence

Related Content

Health Articles

  • Understanding Clinical Trials: A participants' guide

In This Section

Related Clinical Trials

  • Attention Deficit Hyperactivity Disorder
  • Smoking/Smoking Cessation

Share

The purpose of this study is to use functional magnetic resonance imaging (fMRI) to study the neurobiological basis effects of temporarily quitting smoking in response inhibition in attention deficit and hyperactivity disorder (ADHD) smokers and non-ADHD smokers.

Eligibility Requirements

  • Age 18 to 50
  • Smoker
  • May or may not have ADHD

Study Requirements

  • Visits involve a screen (five hours), test and safety visits (five hours), three fMRI scan visits (three hours each), and two follow-up smoke quit checks.
  • Medication in study: methylphenidate (generic Ritalin) and placebo

Compensation

  • Up to $950

For more information, contact Joe English at 919-681-0028.


(REF# 9085)
Contact Us | Careers | Privacy Policy | Make a Gift | Site Map | RSS Feeds | En EspaƱol | Mobile Site | Help
Duke Medicine | Duke School of Medicine | Duke Children's | Duke University
Toll-Free: 888-ASK-DUKE (888-275-3853)
Copyright © 2004-2013 Duke University Health System

About This Page

Updated: Oct. 6, 2011
Published: Nov. 1, 2010
URL: http://www.dukehealth.org/clinicaltrials/neurobiology-of-response-inhibition-in-comorbid-adhd-and-nicotine-dependence